- July 21, 2020
9:00 AM - 3:00 PM ET
Agenda (PDF - 125 KB)
The Food and Drug Administration (FDA or Agency) is announcing a virtual public meeting to discuss the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years (FYs) 2023 through 2027. The virtual public meeting will be held on July 21, 2020, from 9:00 a.m. to 3:00 p.m.
If you would like to attend the meeting, please register here.
- Contact Information for each attendee including name, title, affiliation, email address, and phone number
Registrants will receive instructions to access the live webcast of the virtual meeting.
If you wish to present during a public comment session or participate in a specific session, the email registration should also indicate the desire to do so, and the topic(s) you wish to present. If selected for presentation, you will receive notification by July 8, 2020. All presentation materials must be emailed to GenericDrugPolicy@fda.hhs.gov no later than July 14, 2020.The webcast information, additional materials and any other updates will be posted to this website as they become available.
|GDUFA III Public Meeting Agenda 07.15.2020||pdf (125.85 KB)|